Cargando…

Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy

This population-based study aimed to analyse variations in surgical treatment and guideline compliance with respect to the application of radiotherapy and axillary lymph node dissection (ALND), for early breast cancer, before and after the sentinel node biopsy (SNB) introduction. The study included...

Descripción completa

Detalles Bibliográficos
Autores principales: Schaapveld, M, de Vries, E G E, Otter, R, de Vries, J, Dolsma, W V, Willemse, P H B
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361605/
https://www.ncbi.nlm.nih.gov/pubmed/16136027
http://dx.doi.org/10.1038/sj.bjc.6602747
_version_ 1782153254673580032
author Schaapveld, M
de Vries, E G E
Otter, R
de Vries, J
Dolsma, W V
Willemse, P H B
author_facet Schaapveld, M
de Vries, E G E
Otter, R
de Vries, J
Dolsma, W V
Willemse, P H B
author_sort Schaapveld, M
collection PubMed
description This population-based study aimed to analyse variations in surgical treatment and guideline compliance with respect to the application of radiotherapy and axillary lymph node dissection (ALND), for early breast cancer, before and after the sentinel node biopsy (SNB) introduction. The study included 13 532 consecutive surgically treated stage I–IIIA breast cancer patients diagnosed in 1989–2002. Hospitals showed large variation in breast-conserving surgery (BCS) rates, ranging between 27 and 72% for T1 and 14 and 42% for T2 tumours. In multivariate analysis marked inter-hospital and time-dependent variation in the BCS rate remained after correction for case-mix. The guideline adherence was markedly lower for elderly patients. In 25.2% of the patients aged ⩾75 years either ALND or radiotherapy were omitted. The proportion of patients with no ALND after an SNB increased from 1.8% in 1999 to 37.8% in 2002. However, in 2002 also 12.2% of the patients with a positive SNB did not have an ALND. Guideline compliance for BCS, with respect to radiotherapy and ALND, fell since the SNB introduction, from 96.1% before 2000 to 91.4% in 2002 (P<0.001). Noncompliance may however reflect patient-tailored medicine, as for elderly patients with small, radically resected primary tumours. The considerable variation in BCS-rates is more consistent with variations in surgeon preferences than patient's choice.
format Text
id pubmed-2361605
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23616052009-09-10 Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy Schaapveld, M de Vries, E G E Otter, R de Vries, J Dolsma, W V Willemse, P H B Br J Cancer Clinical Study This population-based study aimed to analyse variations in surgical treatment and guideline compliance with respect to the application of radiotherapy and axillary lymph node dissection (ALND), for early breast cancer, before and after the sentinel node biopsy (SNB) introduction. The study included 13 532 consecutive surgically treated stage I–IIIA breast cancer patients diagnosed in 1989–2002. Hospitals showed large variation in breast-conserving surgery (BCS) rates, ranging between 27 and 72% for T1 and 14 and 42% for T2 tumours. In multivariate analysis marked inter-hospital and time-dependent variation in the BCS rate remained after correction for case-mix. The guideline adherence was markedly lower for elderly patients. In 25.2% of the patients aged ⩾75 years either ALND or radiotherapy were omitted. The proportion of patients with no ALND after an SNB increased from 1.8% in 1999 to 37.8% in 2002. However, in 2002 also 12.2% of the patients with a positive SNB did not have an ALND. Guideline compliance for BCS, with respect to radiotherapy and ALND, fell since the SNB introduction, from 96.1% before 2000 to 91.4% in 2002 (P<0.001). Noncompliance may however reflect patient-tailored medicine, as for elderly patients with small, radically resected primary tumours. The considerable variation in BCS-rates is more consistent with variations in surgeon preferences than patient's choice. Nature Publishing Group 2005-09-05 2005-08-23 /pmc/articles/PMC2361605/ /pubmed/16136027 http://dx.doi.org/10.1038/sj.bjc.6602747 Text en Copyright © 2005 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical Study
Schaapveld, M
de Vries, E G E
Otter, R
de Vries, J
Dolsma, W V
Willemse, P H B
Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy
title Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy
title_full Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy
title_fullStr Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy
title_full_unstemmed Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy
title_short Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy
title_sort guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361605/
https://www.ncbi.nlm.nih.gov/pubmed/16136027
http://dx.doi.org/10.1038/sj.bjc.6602747
work_keys_str_mv AT schaapveldm guidelineadherenceforearlybreastcancerbeforeandafterintroductionofthesentinelnodebiopsy
AT devriesege guidelineadherenceforearlybreastcancerbeforeandafterintroductionofthesentinelnodebiopsy
AT otterr guidelineadherenceforearlybreastcancerbeforeandafterintroductionofthesentinelnodebiopsy
AT devriesj guidelineadherenceforearlybreastcancerbeforeandafterintroductionofthesentinelnodebiopsy
AT dolsmawv guidelineadherenceforearlybreastcancerbeforeandafterintroductionofthesentinelnodebiopsy
AT willemsephb guidelineadherenceforearlybreastcancerbeforeandafterintroductionofthesentinelnodebiopsy